Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Gynecol Oncol. 2021 Sep 8;163(2):378–384. doi: 10.1016/j.ygyno.2021.08.023

Table 1.

Characteristics of eligible women for cervical cancer screening in MarketScan database, 2013–2019.

Year 2013 2014 2015 2016 2017 2018 2019
Total 9,828,405 8,916,074 8,445,231 8,437,170 7,947,718 7,422,148 6,879,860
Age group, y
 <18 21.5% 22.0% 22.6% 22.6% 23.4% 23.5% 23.5%
 18–20 4.1% 4.2% 4.4% 4.4% 4.6% 4.7% 4.8%
 21–24 5.4% 5.6% 5.9% 6.0% 6.3% 6.4% 6.5%
 25–29 4.5% 4.6% 4.7% 4.9% 5.2% 5.2% 5.4%
 30–39 12.3% 12.5% 12.6% 12.9% 13.7% 13.8% 14.1%
 40–49 15.2% 15.1% 14.8% 14.8% 15.2% 15.3% 15.5%
 50–64 25.0% 25.3% 25.4% 25.1% 25.0% 24.9% 24.8%
 65+ 12.0% 10.6% 9.5% 9.4% 6.6% 6.1% 5.4%
Metropolitan residence
 Nonmetro 12.1% 12.0% 11.7% 11.6% 11.1% 11.4% 12.0%
 Metro 87.6% 87.6% 87.9% 88.1% 88.6% 88.3% 87.8%
US Region
 Northeast 16.4% 17.6% 18.3% 18.3% 18.5% 18.4% 19.2%
 Midwest 21.9% 22.8% 24.0% 23.9% 24.1% 25.2% 24.9%
 South 39.5% 42.8% 40.4% 40.4% 40.5% 37.1% 42.2%
 West 21.7% 16.4% 16.9% 17.1% 16.5% 16.3% 13.4%

Percentages bymetropolitan residence and by region do not add up to 100% because, depending on the year, 0.3%–2.6%were not assigned to any region and 0.2%–0.4%were not assigned to a metropolitan residence category.